← Back to headlines
Several Companies Reaffirm 2026 Revenue Guidance
Jazz Pharmaceuticals, AtriCure, and HealthStream have each reaffirmed their respective revenue guidance for 2026. These companies also provided updates on specific product developments and investment strategies.
6 May, 06:52 — 6 May, 06:52
Sources
Showing 1 of 1 sources
